Home › Funds › Paradice Investment Management LLC › GMED

Paradice Investment Management LLC position in GMED

GLOBUS MED INC · Health Care

Paradice Investment Management LLC reported holding 493,588 shares of GMED (GLOBUS MED INC) in its Q3 2026 13F filing — a position valued at US$37.0M, representing 6.59% of its reported portfolio and ranking #4 among its reported holdings. Paradice Investment Management LLC has disclosed GMED holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)493.59K sh
Reported value held$36.97M
Portfolio Weight6.59%
First reportedQ3 2023
Last changeHold
Updated2026-10-21

Last updated: 2026-10-21 · Source: SEC EDGAR Form 13F-HR

How Paradice Investment Management LLC's GMED position evolved

Paradice Investment Management LLC first disclosed a stake in GMED in Q3 2023 at 1,108,815 shares (US$55.1M). Across 13 filings, Paradice Investment Management LLC increased the stake 3 time(s), trimmed it 7 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 493,588 shares valued at US$37.0M. Notable position changes include a 31% trim in Q4 2023 (shares were roughly flat over the following quarter), a 26% trim in Q4 2024 (shares fell 11% over the following quarter), a 26% increase in Q2 2025 (shares fell 3% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.11M $55.05M New
Q4 2023 761.84K $40.60M Reduce
Q1 2024 641.06K $34.39M Reduce
Q2 2024 630.82K $43.20M Reduce
Q3 2024 594.11K $42.50M Reduce
Q4 2024 436.68K $36.12M Reduce
Q1 2025 434.65K $31.82M Hold
Q2 2025 548.61K $32.38M Add
Q3 2025 663.04K $37.97M Add
Q4 2025 528.05K $46.10M Reduce
Q1 2026 491.26K $42.33M Reduce
Q2 2026 493.91K $39.02M Add
Q3 2026 493.59K $36.97M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GMED and 13F data

GMED (GLOBUS MED INC) is a Health Care company. 39 other funds we track also report a position in GMED — the largest reported positions include KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC (US$338.1M), Sculptor Capital LP (US$237.0M), Boston Trust Walden Corp (US$124.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GMED

All GMED fund holders →

FAQ

How long has Paradice Investment Management LLC held GMED?

Paradice Investment Management LLC has disclosed GMED holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Paradice Investment Management LLC's current position in GMED?

As of Q3 2026, Paradice Investment Management LLC holds 493.59K shares of GMED (GLOBUS MED INC), valued at $36.97M, representing 6.59% of its reported portfolio and ranking #4.

Has Paradice Investment Management LLC been buying or selling GMED?

In the latest 13F filing (Q3 2026), Paradice Investment Management LLC held unchanged its position in GMED.

Which other funds hold GMED?

Other major institutional holders of GMED include KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC, Sculptor Capital LP, Boston Trust Walden Corp, among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.